How should insulin and dextrose be administered in a patient with cardiogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

High-Dose Insulin with Dextrose for Cardiogenic Shock

For toxin-induced cardiogenic shock (particularly from calcium channel blockers or beta-blockers), administer high-dose insulin starting with a 1 unit/kg bolus followed by 1 unit/kg/hour infusion, with concurrent dextrose supplementation to maintain euglycemia; however, this therapy has NO role in non-toxin-induced cardiogenic shock or vasoplegic shock where it may worsen outcomes. 1

Critical Context: When to Use vs. Avoid

High-dose insulin is not an antidote but an inodilator with a 15-60 minute onset of action, making it second-line therapy even in appropriate cases 1. The distinction between toxin-induced and other forms of cardiogenic shock is paramount:

Appropriate Use: Toxin-Induced Cardiogenic Shock

  • Primary indications: Calcium channel blocker and beta-blocker overdoses causing cardiogenic shock 2, 3
  • Mechanism: Provides inotropic support through enhanced glucose uptake into cardiac myocytes and peripheral vasodilation 3
  • Documented success with doses ranging from 1-20 units/kg/hour 4, 2

Contraindicated: Vasoplegic Shock

  • Do not use in isolated vasoplegic shock (e.g., dihydropyridine calcium channel blocker overdose) where insulin-induced vasodilation will exacerbate hypotension 1
  • Requires concurrent norepinephrine to counteract vasodilatory effects 1

Administration Protocol

Initial Dosing

  1. Insulin bolus: 1 unit/kg regular insulin IV 3
  2. Dextrose bolus: 25 grams IV (50 mL of 50% dextrose) 3
  3. Insulin infusion: Start at 1 unit/kg/hour 3

Dose Escalation

  • Animal studies demonstrate dose-response relationship with cardiac output improvement up to 10 units/kg/hour 2
  • Case reports document safe escalation to 20 units/kg/hour (highest published dose) over 32 hours 4
  • Titrate based on hemodynamic response, not to a predetermined ceiling

Dextrose Management

Critical: Dextrose administration must be titrated to prevent both hypoglycemia and excessive hyperglycemia.

  • For hypoglycemia treatment: Administer 10-20 grams IV dextrose (NOT the traditional 25-50 grams) 5
  • Preferred method: 10% dextrose in 50 mL (5-gram) aliquots repeated every minute until symptoms resolve 5
  • Avoid: Rapid administration of 50% dextrose, which causes excessive BG elevation and has been associated with cardiac arrest and hyperkalemia 5
  • Maximum safe infusion rate: 0.5 g/kg/hour for peripheral administration; 0.8 g/kg/hour retains 95% of dextrose 6

Monitoring Requirements

Glucose Monitoring

  • Frequency: Every 1-2 hours during insulin infusion 5
  • Target: Maintain euglycemia (avoid both hypoglycemia and hyperglycemia >180 mg/dL)
  • Every 4-hour testing produces hypoglycemia rates >10% and is inadequate 5

Electrolyte Monitoring

  • Potassium: Check frequently; hypokalemia is predictable and can persist beyond insulin cessation 1
  • Hypoglycemia and hypokalemia are the primary adverse effects requiring vigilant monitoring 4, 1

Hemodynamic Monitoring

  • Expect 15-60 minute delay before hemodynamic improvement 1
  • In successful cases, documented improvement from LVEF 10-15% to 50-55% within 3.5 hours 7

Concurrent Vasopressor Support

Mandatory: Use norepinephrine concurrently to counteract insulin-induced vasodilation 1. High-dose insulin should never be used as monotherapy for cardiogenic shock.

Common Pitfalls

  1. Using in wrong shock type: Insulin worsens vasoplegic shock; only use for cardiogenic shock from toxins 1
  2. Inadequate glucose monitoring: Every 4-hour checks are insufficient 5
  3. Excessive dextrose boluses: Traditional 50-gram doses cause rebound hyperglycemia; use 10-20 grams 5
  4. Expecting immediate effect: Onset takes 15-60 minutes, unlike catecholamines 1
  5. Ignoring potassium: Hypokalemia develops predictably and requires replacement 1

Evidence Quality Note

While animal studies show clear dose-response relationships 2 and case series demonstrate survival in otherwise fatal overdoses 8, 3, no randomized controlled trials exist for high-dose insulin in human cardiogenic shock. The evidence base consists of animal models and case reports/series. Recent expert recommendations for cardiogenic shock management do not include high-dose insulin for non-toxin etiologies 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.